America Latina Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on America Latina Times.

Press releases published on July 7, 2026

Jul. 7, 2026

SurancePlus Successfully Closes on Five (5) RWA Securities Offerings on Solana Raising $7.1 million and Expanding Tokenized RWA Platform

Indeterminate GlobeNewswire

Jul. 7, 2026

Enlivex Announces 1-for-15 Reverse Stock Split Effective July 9, 2026

Indeterminate GlobeNewswire

Jul. 7, 2026

Clearmind Reports Successful Formulation Feasibility Study Supporting Potential New Additional Route of Administration Development for MEAI

Indeterminate GlobeNewswire

Jul. 7, 2026

Acumen Pharmaceuticals to Present Data on Enhanced Brain Delivery™ (EBD™) Technology and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026

Indeterminate GlobeNewswire

Jul. 7, 2026

Fredonia Provides El Dorado Monserrat Project and Corporate Update

Indeterminate GlobeNewswire

Jul. 7, 2026

Nuvini Retires R$61 Million Debenture Facility in Full

Indeterminate GlobeNewswire

Jul. 7, 2026

U.S. FDA Grants Priority Review to Agios’ sNDA for Mitapivat in Sickle Cell Disease

Indeterminate GlobeNewswire

Jul. 7, 2026

VR completes 2,900 ft hole and polyphase vein intersection at its New Boston Moly-Tungsten-Copper-Silver Porphyry Project in Nevada; core scanning and continuous geochemistry are underway

Indeterminate GlobeNewswire

Jul. 7, 2026

Stallion Uranium Defines Priority Target Areas from VTEM Survey on Stone Island Target, Moonlite Project

Indeterminate GlobeNewswire

Jul. 7, 2026

OKYO Pharma to Participate in a Fireside Chat at Piper Sandler 2026 Virtual Ophthalmology Symposium

Indeterminate GlobeNewswire

Jul. 7, 2026

Kailera Therapeutics Announces Positive Topline Data from Two Hengrui Pharma Phase 3 Clinical Trials of Oral Small Molecule GLP-1 Receptor Agonist HRS-7535/KAI-7535

Indeterminate GlobeNewswire

Jul. 7, 2026

Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP

Indeterminate GlobeNewswire

Jul. 7, 2026

Titan Confirms District-Wide Germanium Enrichment as Critical Mineral Push Expands at Empire State Mines

Indeterminate GlobeNewswire

Jul. 7, 2026

ITM Announces Primary Results from the Phase 3 COMPETE Trial Published in The Lancet Comparing ¹⁷⁷Lu-edotreotide (ITM-11) vs. Everolimus in Advanced GEP-NETs

Indeterminate GlobeNewswire

Jul. 7, 2026

Presentation of New Clinical Data on Givinostat in Duchenne Muscular Dystrophy at ICNMD 2026

Indeterminate GlobeNewswire

Jul. 7, 2026

Bitget Upgrades Institutional Trading Framework to Power the Next Phase of Multi-Asset Markets

Indeterminate GlobeNewswire